Discovering the mechanisms underlying oncogenesis by ZFTA-RELA and pinpointing therapeutic targets.
Project Number1U01CA294103-01
Contact PI/Project LeaderMACK, STEPHEN C Other PIs
Awardee OrganizationST. JUDE CHILDREN'S RESEARCH HOSPITAL
Description
Abstract Text
PROJECT SUMMARY:
Ependymoma (EPN) is an aggressive and chemo-resistant pediatric brain tumor, with treatment remaining
surgery and radiation. There are no targeted therapies available to EPN patients at diagnosis or relapse. Over
95% of EPN that arise in the cortex are driven by gene fusions of ZFTA, with ZFTA-RELA fusions (denoted
ZRFUS) being the most common. We and others have developed mouse models of ZRFUS EPN and found that
ZRFUS binds novel genomic loci to activate oncogenic gene expression and drive tumor formation. Despite these
advances, key knowledge gaps regarding ZRFUS biology remain, including: 1) The precise mechanisms of
oncogenic gene expression, including recruitment of co-regulatory factors, following ZRFUS DNA binding, 2) How
the structured domains and intrinsically disordered regions (IDRs) within the ZRFUS protein synergistically
contribute to oncogene activation, and 3) How ZRFUS interaction partners contribute to oncogenesis and whether
they represent therapeutic vulnerabilities. Emerging evidence from us and others across multiple pediatric
cancers has linked fusion oncoprotein (FO) expression to biomolecular condensate formation, possibly through
a phase separation (PS) mechanism, as a possible unifying model of oncogenic gene expression. We
demonstrate that ZRFUS forms dynamic, nuclear condensates, and that key ZRFUS IDRs are necessary for
condensate formation, oncogenic gene expression and tumorigenesis. In addition to identifying several long
IDRs within ZRFUS, we have discovered that the ZFTA zinc finger (ZF) domains in ZRFUS dominantly influence
DNA binding, condensate formation, and oncogenic gene expression. Based on these preliminary data, we
hypothesize that: ZRFUS forms chromatin-associated, liquid-like condensates that are necessary for oncogenic
gene expression and tumor development. To address this hypothesis, we propose the following three
objectives/aims, to (1) Understand how ZRFUS condensates regulate oncogenic expression and tumor
development, (2) Discover the structural basis of ZFTA zinc finger DNA binding and its role in tumorigenesis,
and (3) Interrogate ZRFUS interacting proteins as cancer dependency proteins and therapeutic targets. Overall,
we anticipate that deciphering the mechanisms underlying oncogenesis by ZRFUS, including the biophysics of
condensate formation and functional roles of its condensate interaction partners, may yield novel therapeutic
targets for this aggressive disease.
Public Health Relevance Statement
NARRATIVE
The overall goal of this proposal is to understand the mechanistic basis of ZFTA-RELA ependymoma, with a
specific focus on biomolecular condensates and impact on gene transcription and tumorigenesis. Our studies
will also evaluate the contribution of ZFTA-RELA interacting proteins as cell proliferative dependencies, and
therapeutic targets.
No Sub Projects information available for 1U01CA294103-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01CA294103-01
Patents
No Patents information available for 1U01CA294103-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01CA294103-01
Clinical Studies
No Clinical Studies information available for 1U01CA294103-01
News and More
Related News Releases
No news release information available for 1U01CA294103-01
History
No Historical information available for 1U01CA294103-01
Similar Projects
No Similar Projects information available for 1U01CA294103-01